Brandywine Managers’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $162K | Hold |
|
|||||
|
2024
Q1 | $247K | Hold |
|
|||||
|
2023
Q4 | $176K | Hold |
|
|||||
|
2023
Q3 | $116K | Hold |
|
|||||
|
2023
Q2 | $86.2K | Hold |
|
|||||
|
2023
Q1 | $74.5K | Hold |
|
|||||
|
2022
Q4 | $190K | Hold |
|
|||||
|
2022
Q3 | $211K | Hold |
|
|||||
|
2022
Q2 | $128K | Hold |
|
|||||
|
2022
Q1 | $618K | Buy |
|
|||||
|
2021
Q4 | $447K | Buy |
|
|||||
|
2021
Q3 | $575K | Hold |
|
|||||
|
2021
Q2 | $214K | Hold |
|
|||||
|
2021
Q1 | $240K | Hold |
|
|||||
|
2020
Q4 | $239K | Hold |
|
|||||
|
2020
Q3 | $162K | Buy |
|
|||||
|
2020
Q2 | $281K | Hold |
|
|||||
|
2020
Q1 | $184K | Buy |
|
|||||
|
2019
Q4 | $189K | Sell |
|
|||||
|
2019
Q3 | $197K | Buy |
|